Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soleil Securities Group was an independent equity research and brokerage firm that provided institutional investors with specialized market insights. The firm operated by partnering with boutique research firms and independent analysts to offer coverage in sectors such as healthcare, technology, and consumer goods. In addition to its research offerings, the company provided equity trading and distribution services to its institutional client base. In February 2011, Soleil Securities was acquired by Ticonderoga Securities, which integrated Soleil's research and sales capabilities into its own platform. The firm was well-regarded for its 'unbundled' research model, which allowed it to provide diverse perspectives to the investment community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soleil Securities Group.